相似文献
1
Molecular epidemiological characterization of uropathogenic escherichia coli from an outpatient urology clinic in rural Japan.
J Clin Microbiol. 2015 Feb;53(2):681-3. doi: 10.1128/JCM.03068-14. Epub 2014 Nov 26.
2
Prevalence of fluoroquinolone-resistant and broad-spectrum cephalosporin-resistant community-acquired urinary tract infections in Rio de Janeiro: Impact of Escherichia coli genotypes ST69 and ST131.
Infect Genet Evol. 2020 Nov;85:104452. doi: 10.1016/j.meegid.2020.104452. Epub 2020 Jul 4.
3
Ciprofloxacin resistance in uropathogenic Escherichia coli isolates causing community-acquired urinary infections in Brasília, Brazil.
J Glob Antimicrob Resist. 2017 Jun;9:61-67. doi: 10.1016/j.jgar.2017.01.009. Epub 2017 Apr 15.
4
Epidemiology and genotypic characterisation of dissemination patterns of uropathogenic Escherichia coli in a community.
Epidemiol Infect. 2019 Jan;147:e148. doi: 10.1017/S0950268819000426.
5
Molecular Epidemiology of Antimicrobial Resistance of Uropathogenic Isolates from Patients with Urinary Tract Infections in a Tertiary Teaching Hospital in Iran.
Microb Drug Resist. 2020 Jan;26(1):60-70. doi: 10.1089/mdr.2019.0184. Epub 2019 Sep 17.
6
Clonal composition of Escherichia coli causing community-acquired urinary tract infections in the State of Rio de Janeiro, Brazil.
Microb Drug Resist. 2009 Dec;15(4):303-8. doi: 10.1089/mdr.2009.0067.
7
Persistent Pandemic Lineages of Uropathogenic Escherichia coli in a College Community from 1999 to 2017.
J Clin Microbiol. 2018 Mar 26;56(4). doi: 10.1128/JCM.01834-17. Print 2018 Apr.
8
Antibiotic resistance, virulence factors and genotyping of Uropathogenic strains.
Antimicrob Resist Infect Control. 2018 Oct 3;7:118. doi: 10.1186/s13756-018-0411-4. eCollection 2018.
9
Virulence genes, quinolone and fluoroquinolone resistance, and phylogenetic background of uropathogenic Escherichia coli strains isolated in Japan.
Jpn J Infect Dis. 2010 Mar;63(2):113-5.
10
Lower prevalence of hlyD, papC and cnf-1 genes in ciprofloxacin-resistant uropathogenic Escherichia coli than their susceptible counterparts isolated from southern India.
J Infect Public Health. 2014 Sep-Oct;7(5):413-9. doi: 10.1016/j.jiph.2014.04.002. Epub 2014 May 23.
引用本文的文献
1
Molecular characterization of uropathogenic (UPEC) strains isolated from companion dogs and cats in Korea.
J Vet Sci. 2025 Jan;26(1):e14. doi: 10.4142/jvs.24244.
2
Distinguishing Pathovars from Nonpathovars: Escherichia coli.
Microbiol Spectr. 2020 Dec;8(4). doi: 10.1128/microbiolspec.AME-0014-2020.
3
Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages.
Clin Microbiol Rev. 2019 Jun 12;32(3). doi: 10.1128/CMR.00135-18. Print 2019 Jun 19.
4
Epidemiology and genotypic characterisation of dissemination patterns of uropathogenic Escherichia coli in a community.
Epidemiol Infect. 2019 Jan;147:e148. doi: 10.1017/S0950268819000426.
5
Persistent Pandemic Lineages of Uropathogenic Escherichia coli in a College Community from 1999 to 2017.
J Clin Microbiol. 2018 Mar 26;56(4). doi: 10.1128/JCM.01834-17. Print 2018 Apr.
本文引用的文献
1
Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E. coli ST131.
Ann Clin Microbiol Antimicrob. 2014 Jan 7;13:4. doi: 10.1186/1476-0711-13-4.
2
Antimicrobial resistance in commensal Escherichia coli in veal calves is associated with antimicrobial drug use.
Epidemiol Infect. 2014 Sep;142(9):1893-904. doi: 10.1017/S0950268813002665. Epub 2013 Oct 24.
3
Poultry as reservoir for extraintestinal pathogenic Escherichia coli O45:K1:H7-B2-ST95 in humans.
Vet Microbiol. 2013 Dec 27;167(3-4):506-12. doi: 10.1016/j.vetmic.2013.08.007. Epub 2013 Aug 18.
4
Molecular characteristics of extended-spectrum β-lactamases in clinical isolates from Escherichia coli at a Japanese tertiary hospital.
PLoS One. 2013 May 15;8(5):e64359. doi: 10.1371/journal.pone.0064359. Print 2013.
5
Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus.
J Infect Chemother. 2013 Jun;19(3):393-403. doi: 10.1007/s10156-013-0606-9. Epub 2013 May 3.
6
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.
Clin Microbiol Infect. 2012 Mar;18(3):268-81. doi: 10.1111/j.1469-0691.2011.03570.x. Epub 2011 Jul 27.
7
The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy.
J Infect Chemother. 2011 Feb;17(1):126-38. doi: 10.1007/s10156-010-0174-1. Epub 2010 Dec 21.
8
[In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,919 clinical isolates obtained from 72 centers in 2007].
Jpn J Antibiot. 2009 Aug;62(4):346-70.
9
Extraintestinal pathogenic Escherichia coli O1:K1:H7/NM from human and avian origin: detection of clonal groups B2 ST95 and D ST59 with different host distribution.
BMC Microbiol. 2009 Jul 7;9:132. doi: 10.1186/1471-2180-9-132.
10
Global spread of mobile antimicrobial drug resistance determinants in human and animal Escherichia coli and Salmonella strains causing community-acquired infections.
Clin Infect Dis. 2009 Aug 1;49(3):365-71. doi: 10.1086/600301.
Zotero 插件